Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AHR

American Healthcare REIT Raises Quarterly Distribution by 4%

American Healthcare REIT, Inc. (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for the quarter ending June 30, 2025. This marks a 4% increase from the previous quarter's distribution of $0.24 per share.

The company, which focuses primarily on senior housing communities, skilled nursing, and outpatient medical buildings across the United States, as well as in the United Kingdom and the Isle of Man, has continued to strengthen its financial position. In the second quarter of 2025, American Healthcare REIT reported a 6% increase in its funds from operations (FFO) to $1.20 per share, up from $1.13 per share in the previous quarter.

Furthermore, the company's net operating income (NOI) saw a significant uptick, rising by 8% to $45 million in the second quarter of 2025, compared to $41.6 million in the first quarter of the same year.

In addition, American Healthcare REIT's occupancy rates for its senior housing communities and skilled nursing facilities have shown resilience, standing at an average of 92% for the second quarter of 2025.

These positive financial indicators reflect the company's commitment to delivering value to its shareholders while maintaining strong operational performance across its diversified portfolio of clinical healthcare real estate. Following these announcements, the company's shares moved 0.36%, and are now trading at a price of $35.87. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS